BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

807 related articles for article (PubMed ID: 34379917)

  • 1. Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
    Hall VG; Ferreira VH; Ku T; Ierullo M; Majchrzak-Kita B; Chaparro C; Selzner N; Schiff J; McDonald M; Tomlinson G; Kulasingam V; Kumar D; Humar A
    N Engl J Med; 2021 Sep; 385(13):1244-1246. PubMed ID: 34379917
    [No Abstract]   [Full Text] [Related]  

  • 2. A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response: Erratum.
    Transplantation; 2024 May; 108(5):e78. PubMed ID: 38659119
    [No Abstract]   [Full Text] [Related]  

  • 3. Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines.
    Al Jalali V; Scherzer S; Zeitlinger M
    Clin Microbiol Infect; 2021 Oct; 27(10):1529-1530. PubMed ID: 34192576
    [No Abstract]   [Full Text] [Related]  

  • 4. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
    Normark J; Vikström L; Gwon YD; Persson IL; Edin A; Björsell T; Dernstedt A; Christ W; Tevell S; Evander M; Klingström J; Ahlm C; Forsell M
    N Engl J Med; 2021 Sep; 385(11):1049-1051. PubMed ID: 34260850
    [No Abstract]   [Full Text] [Related]  

  • 5. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
    Widge AT; Rouphael NG; Jackson LA; Anderson EJ; Roberts PC; Makhene M; Chappell JD; Denison MR; Stevens LJ; Pruijssers AJ; McDermott AB; Flach B; Lin BC; Doria-Rose NA; O'Dell S; Schmidt SD; Neuzil KM; Bennett H; Leav B; Makowski M; Albert J; Cross K; Edara VV; Floyd K; Suthar MS; Buchanan W; Luke CJ; Ledgerwood JE; Mascola JR; Graham BS; Beigel JH;
    N Engl J Med; 2021 Jan; 384(1):80-82. PubMed ID: 33270381
    [No Abstract]   [Full Text] [Related]  

  • 6. SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.
    Falsey AR; Frenck RW; Walsh EE; Kitchin N; Absalon J; Gurtman A; Lockhart S; Bailey R; Swanson KA; Xu X; Koury K; Kalina W; Cooper D; Zou J; Xie X; Xia H; Türeci Ö; Lagkadinou E; Tompkins KR; Shi PY; Jansen KU; Şahin U; Dormitzer PR; Gruber WC
    N Engl J Med; 2021 Oct; 385(17):1627-1629. PubMed ID: 34525276
    [No Abstract]   [Full Text] [Related]  

  • 7. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.
    Kamar N; Abravanel F; Marion O; Couat C; Izopet J; Del Bello A
    N Engl J Med; 2021 Aug; 385(7):661-662. PubMed ID: 34161700
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19.
    Boyarsky BJ; Barbur I; Chiang TP; Ou MT; Greenberg RS; Teles AT; Krach MR; López JI; Garonzik-Wang JM; Avery RK; Massie AB; Segev DL; Werbel WA
    Transplantation; 2021 Nov; 105(11):e270-e271. PubMed ID: 34284420
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of neutralizing antibody responses against SARS-CoV-2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier?
    Terpos E; Trougakos IP; Karalis V; Ntanasis-Stathopoulos I; Sklirou AD; Bagratuni T; Papanagnou ED; Patseas D; Gumeni S; Malandrakis P; Korompoki E; Dimopoulos MA
    Am J Hematol; 2021 Sep; 96(9):E321-E324. PubMed ID: 34028867
    [No Abstract]   [Full Text] [Related]  

  • 10. Audio Interview: New Evidence on SARS-CoV-2 Vaccine Boosters.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Sep; 385(12):e48. PubMed ID: 34525292
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine : Secondary Analysis of a Randomized Trial.
    Kumar D; Ferreira VH; Hall VG; Hu Q; Samson R; Ku T; Ierullo M; Majchrzak-Kita B; Tomlinson G; Gingras AC; Humar A
    Ann Intern Med; 2022 Feb; 175(2):226-233. PubMed ID: 34807716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.
    Pegu A; O'Connell SE; Schmidt SD; O'Dell S; Talana CA; Lai L; Albert J; Anderson E; Bennett H; Corbett KS; Flach B; Jackson L; Leav B; Ledgerwood JE; Luke CJ; Makowski M; Nason MC; Roberts PC; Roederer M; Rebolledo PA; Rostad CA; Rouphael NG; Shi W; Wang L; Widge AT; Yang ES; ; Beigel JH; Graham BS; Mascola JR; Suthar MS; McDermott AB; Doria-Rose NA; Arega J; Beigel JH; Buchanan W; Elsafy M; Hoang B; Lampley R; Kolhekar A; Koo H; Luke C; Makhene M; Nayak S; Pikaart-Tautges R; Roberts PC; Russell J; Sindall E; Albert J; Kunwar P; Makowski M; Anderson EJ; Bechnak A; Bower M; Camacho-Gonzalez AF; Collins M; Drobeniuc A; Edara VV; Edupuganti S; Floyd K; Gibson T; Ackerley CMG; Johnson B; Kamidani S; Kao C; Kelley C; Lai L; Macenczak H; McCullough MP; Peters E; Phadke VK; Rebolledo PA; Rostad CA; Rouphael N; Scherer E; Sherman A; Stephens K; Suthar MS; Teherani M; Traenkner J; Winston J; Yildirim I; Barr L; Benoit J; Carste B; Choe J; Dunstan M; Erolin R; Ffitch J; Fields C; Jackson LA; Kiniry E; Lasicka S; Lee S; Nguyen M; Pimienta S; Suyehira J; Witte M; Bennett H; Altaras NE; Carfi A; Hurley M; Leav B; Pajon R; Sun W; Zaks T; Coler RN; Larsen SE; Neuzil KM; Lindesmith LC; Martinez DR; Munt J; Mallory M; Edwards C; Baric RS; Berkowitz NM; Boritz EA; Carlton K; Corbett KS; Costner P; Creanga A; Doria-Rose NA; Douek DC; Flach B; Gaudinski M; Gordon I; Graham BS; Holman L; Ledgerwood JE; Leung K; Lin BC; Louder MK; Mascola JR; McDermott AB; Morabito KM; Novik L; O'Connell S; O'Dell S; Padilla M; Pegu A; Schmidt SD; Shi W; Swanson PA; Talana CA; Wang L; Widge AT; Yang ES; Zhang Y; Chappell JD; Denison MR; Hughes T; Lu X; Pruijssers AJ; Stevens LJ; Posavad CM; Gale M; Menachery V; Shi PY
    Science; 2021 Sep; 373(6561):1372-1377. PubMed ID: 34385356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.
    Boyarsky BJ; Werbel WA; Avery RK; Tobian AAR; Massie AB; Segev DL; Garonzik-Wang JM
    JAMA; 2021 Jun; 325(21):2204-2206. PubMed ID: 33950155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern.
    Yue L; Zhou J; Zhou Y; Yang X; Xie T; Yang M; Zhao H; Zhao Y; Yang T; Li H; Xiang H; Wang J; Lu S; Liu H; Zhao H; Wei X; Zhang Y; Xie Z
    Emerg Microbes Infect; 2021 Dec; 10(1):2125-2127. PubMed ID: 34666622
    [No Abstract]   [Full Text] [Related]  

  • 15. Third Time's a Charm - Covid-19 Vaccine Hope for Solid-Organ Transplant Recipients.
    Williams WW; Ingelfinger JR
    N Engl J Med; 2021 Sep; 385(13):1233-1234. PubMed ID: 34379913
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine-boosted nonhuman primates.
    Corbett KS; Gagne M; Wagner DA; O' Connell S; Narpala SR; Flebbe DR; Andrew SF; Davis RL; Flynn B; Johnston TS; Stringham CD; Lai L; Valentin D; Van Ry A; Flinchbaugh Z; Werner AP; Moliva JI; Sriparna M; O'Dell S; Schmidt SD; Tucker C; Choi A; Koch M; Bock KW; Minai M; Nagata BM; Alvarado GS; Henry AR; Laboune F; Schramm CA; Zhang Y; Yang ES; Wang L; Choe M; Boyoglu-Barnum S; Wei S; Lamb E; Nurmukhambetova ST; Provost SJ; Donaldson MM; Marquez J; Todd JM; Cook A; Dodson A; Pekosz A; Boritz E; Ploquin A; Doria-Rose N; Pessaint L; Andersen H; Foulds KE; Misasi J; Wu K; Carfi A; Nason MC; Mascola J; Moore IN; Edwards DK; Lewis MG; Suthar MS; Roederer M; McDermott A; Douek DC; Sullivan NJ; Graham BS; Seder RA
    Science; 2021 Dec; 374(6573):1343-1353. PubMed ID: 34672695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant.
    Zhao X; Li D; Ruan W; Chen Z; Zhang R; Zheng A; Qiao S; Zheng X; Zhao Y; Dai L; Han P; Gao GF
    N Engl J Med; 2022 Mar; 386(9):894-896. PubMed ID: 35081296
    [No Abstract]   [Full Text] [Related]  

  • 18. Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.
    Edara VV; Pinsky BA; Suthar MS; Lai L; Davis-Gardner ME; Floyd K; Flowers MW; Wrammert J; Hussaini L; Ciric CR; Bechnak S; Stephens K; Graham BS; Bayat Mokhtari E; Mudvari P; Boritz E; Creanga A; Pegu A; Derrien-Colemyn A; Henry AR; Gagne M; Douek DC; Sahoo MK; Sibai M; Solis D; Webby RJ; Jeevan T; Fabrizio TP
    N Engl J Med; 2021 Aug; 385(7):664-666. PubMed ID: 34233096
    [No Abstract]   [Full Text] [Related]  

  • 19. Standardised neutralising antibody assays are needed for evaluating COVID-19 vaccines.
    Wang Y
    EBioMedicine; 2021 Nov; 73():103677. PubMed ID: 34742128
    [No Abstract]   [Full Text] [Related]  

  • 20. A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine.
    Yue L; Xie T; Yang T; Zhou J; Chen H; Zhu H; Li H; Xiang H; Wang J; Yang H; Zhao H; Wei X; Zhang Y; Xie Z
    J Med Virol; 2022 Jan; 94(1):35-38. PubMed ID: 34516026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 41.